Barr Fluoxetine Generic Exclusivity Claim Faces Hurdles
Barr's claim to 180 days of generic exclusivity for fluoxetine will depend on the outcome of judicial and regulatory proceedings over the next year.
Barr's claim to 180 days of generic exclusivity for fluoxetine will depend on the outcome of judicial and regulatory proceedings over the next year.